2-Phenylmelatonin: A partial agonist at enteric melatonin receptors

Pharmacology and Toxicology

Volumn 87, Issue 4, 2000, Pages 156-160

  Santagostino Barbone, Maria Grazia ^a   Masoero, Elisabetta ^a   Spelta, Valeria ^a   Lucehelli, Adele ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 PHENYLMELATONIN; MELATONIN; MELATONIN DERIVATIVE; MELATONIN RECEPTOR; PRAZOSIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ASCENDING COLON; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; GUINEA PIG; INTESTINE CONTRACTION; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033791901     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.pto870402.x     Document Type: Article

References (18)

1. Alexander, S. & J. Peters: Trends Pharmacol. Sci. Receptor & Ion channel Nomenclature Supplement 2000, 11th ed.
2. Chen, J. J., B. Fiehn-Schulze, P. A. Brough, V. Snieckus & G. Firnau: Synthesis of 2-iodo and 2- phenyl[11C]melatonin: potential PET tracers for melatonin binding sites. Appl. Radiation & Isotopes 1998, 49, 1573-1579.
3. Davies, D. J., P. J. Garratt, D. A. Tocher, S. Vonhoff, J. Davies, M. T. Teh & D. Sugden: Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles. J. Med. Chem. 1998, 41, 451-467.
4. Dubocovich, M. L.: Melatonin receptors: are there multiple subtypes? Trends Pharmacol. Sci. 1995, 16, 50-56.
5. 1 presynaptic heteroreceptor. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997, 355, 365-375.
6. 2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J. 1998, 12, 1211-1220.
7. Eison, A. S. & U. L. Mullins: Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in syrian hamster RPMI 1846 melanoma cells. Life Sci. 1993, 53, PL393-PL398.
8. 4 receptors in guinea-pig ascending colon. Eur. J. Pharmacol. 1991, 196, 149-155.
9. Garratt, P. J., R. Jones & D. A. Tocher: Mapping the melatonin receptor. 3. Design and synthesis of melatonin agonists and antagonists derived from 2-phenyltryptamines. J. Med. Chem. 1995, 38, 1132-1139.
10. 4 and melatonin receptors. Brit. J. Pharmacol. 1997, 121, 1775-1781.
11. 2 sites. Eur. J. Pharmacol. 1996, 301, 159-168.
12. 1a receptor following stable transfection into NIH3T3 cells. Brit. J. Pharmacol. 1998, 124, 485-492.
13. 125I]Iodomelatonin binding sites in the quail heart: characteristics, distribution and modulation by guanine nucleotides and cations. Life Sci. 1996, 58, 1047-1057.
14. Popova, J. S. & M. L. Dubocovich: Melatonin receptor-mediated stimulation of phosphoinositide breakdown in chick brain slices. J. Neurochem. 1995, 64, 130-138.
15. Reppert, S. M., D. R. Weaver & C. Godson: Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol. Sci. 1996, 17, 100-102.
16. Spadoni, G., B. Stankov, A. Duranti, G. Biella, V. Lucini, A. Salvatori & F. Fraschini: 2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity. J. Med. Chem. 1993, 36, 4069-4074.
17. Spadoni, G., C. Balsamini, A. Bedini, G. Diamantini, B. Di Giacomo, A. Tontini, G. Tarzia, M. Mor, P. V. Plazzi, S. Rivara, R. Nonno, M. Pannacci, V. Lucini, F. Fraschini & B. Stankov: 2-[N-Acylamino(C1-C3)alkyl]indoles as MT, melatonin receptor partial agonists, antagonists, and putative inverse agonists. J. Med. Chem. 1998, 41, 3624-3634.
18. Sugden, D.: Effect of putative melatonin receptor antagonists on melatonin-induced pigment aggregation in isolated Xenopus Laeris melanophores. Eur. J. Pharmacol. 1992, 213, 405-408.